JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, an enhanced resveratrol formulation for Parkinson's disease and other CNS/neuroinflammation disorders, alongside its Nugevia longevity supplement line.
2 Pulse stories
TB
Triveni BioClinical-stage biotech developing genetics-informed antibody therapeutics for immunological and inflammatory diseases.
2 Pulse stories
Total Raised
$272M
Jupiter NeurosciencesTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
2023
Jupiter, Florida
HQ
Watertown, Massachusetts
Public (JUNS)
Status
Private
Jupiter Neurosciences investors
No investors on record.
Triveni Bio investors
Ascenta CapitalJanus Henderson InvestorsDeep Track Capital
Data from Value Add Pulse coverage and company research — see the full threads for Jupiter Neurosciences and Triveni Bio.